Fundz

Ring Therapeutics Raises $86.5 Million In Series C Funding To Create Next Generation Programmable Medicines

PRIVATEMar 09, 2023

Amount Raised

$86.5 Million

Round Type

Series C

CambridgeBiotechnologyHealth Care

Description

Ring Therapeutics, a life sciences company founded by Flagship Pioneering to revolutionize gene therapy with its commensal virome platform, today announced that it raised $86.5 million in Series C funding, bringing its total funds raised to date to $230 million. Investors included Alexandria Venture Investments; Altitude Life Science Ventures; CJ Investment; Ring’s founder, Flagship Pioneering; Invus; Kyowa Kirin Co., Ltd; Partners Investment; funds and accounts advised by T. Rowe Price Associates, Inc.; UPMC Enterprises, and others including all of Ring’s existing institutional shareholders.

Quick answer

Ring raised $86.5 Million in a Series C round, dated March 9, 2023. Ring is based in Cambridge, Maryland, United States.

How much did Ring raise?
Ring raised $86.5 Million in a Series C round on March 9, 2023.
What does Ring do?
The company developed the Anellogy™ platform which focuses on anelloviruses to potentially treat a broad range of diseases.
Where is Ring based and how big is it?
Ring is based in Cambridge, Maryland, United States. Fundz records about 47 employees.
Who are the decision-makers at Ring?
Fundz holds 1 contact at Ring. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as Ring that raised within 45 days of this round, from Fundz verified event records.

  • Trellis Bioscience raised $1.4M on April 20, 2023.
  • Lifeist Wellness raised an undisclosed amount (Debt Financing) on April 20, 2023.
  • Phio Pharmaceuticals raised $4M (Seed) on April 20, 2023.
  • MedShift raised $108M (Funding Round) on April 20, 2023.
  • Hasten Biopharmaceutic Ltd raised $315M (Funding Round) on April 20, 2023.
  • Legend Biotech raised $200M on April 19, 2023.

Who to call at Ring, and when

A new round usually means Ring is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Ring raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Ring, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Ring. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Ring

Location

Cambridge, Maryland, United States

About

The company developed the Anellogy™ platform which focuses on anelloviruses to potentially treat a broad range of diseases. Since its launch in 2000, the firm has, through its Flagship Labs unit, applied its unique hypothesis-driven innovation process to originate and foster more than 100 scientific ventures, resulting in more than $100 billion in aggregate value. Ring has developed the world’s first and only platform, the Anellogy™ platform, to discover and harness the unique characteristics of these viruses as programmable medicines capable of delivering a wide array of payloads including DNA and RNA in a highly-tropic, redosable manner. Through its Anellogy™ platform, Ring has developed the largest anellovirus database to date, having sequenced and identified over 5,000 anelloviruses from human samples.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Ring raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Ring's next move

See what Strategic adds

Ring raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.